Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis

CD49d blockade by natalizumab therapy in patients with multiple sclerosis increases immature B-lymphocytes

(2011) J-F Lesesve et al.   BONE MARROW TRANSPLANTATION

Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients

(2011) Mario Skarica et al.   JOURNAL OF NEUROIMMUNOLOGY

CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function

(2010) D Jing et al.   BONE MARROW TRANSPLANTATION

Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells

(2010) Norman Putzki et al.   EUROPEAN NEUROLOGY

Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity

(2010) L. J. Marshall et al.   JOURNAL OF GENERAL VIROLOGY

Regulation of Follicular B Cell Differentiation by the Related E26 Transformation-Specific Transcription Factors PU.1, Spi-B, and Spi-C

(2010) R. P. DeKoter et al.   JOURNAL OF IMMUNOLOGY

JC Virus Latency in the Brain and Extraneural Organs of Patients with and without Progressive Multifocal Leukoencephalopathy

(2010) C. S. Tan et al.   JOURNAL OF VIROLOGY

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

(2010) Samantha Jilek et al.   LANCET NEUROLOGY

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

(2010) Chen S Tan et al.   LANCET NEUROLOGY

CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus

(2010) Clemens Warnke et al.   Multiple Sclerosis Journal

Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment

(2010) P Wipfler et al.   Multiple Sclerosis Journal

Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies

(2009) Eugene O. Major   Annual Review of Medicine

Detection of JC Virus DNA and Proteins in the Bone Marrow of HIV‐Positive and HIV‐Negative Patients: Implications for Viral Latency and Neurotropic Transformation

(2009) Chen S. Tan et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors

(2009) Adrian Egli et al.   JOURNAL OF INFECTIOUS DISEASES

β1integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity

(2009) Martina Bauer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab

(2008) Maria del Pilar Martin   ARCHIVES OF NEUROLOGY

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

(2008) F. Zohren et al.   BLOOD

Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab

(2008) H. Bonig et al.   BLOOD

The bone marrow, B cells, and JC virus

(2008) Sidney A Houff et al.   JOURNAL OF NEUROVIROLOGY

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

(2008) M. Krumbholz et al.   NEUROLOGY